Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: Results from a multicenter, prospective, randomized, double-blinded, controlled study: The INTERSEPT Study

Critical Care

Volumn 15, Issue 3, 2011, Pages

  Pontes Arruda, Alessandro ^a   Martins, Laércia F ^a   de Lima, Samya M ^a   Isola, Alexandre M ^b   Toledo, Diogo ^b   Rezende, Ederlon ^b   Maia, Marcelo ^c   Magnan, Gisele B ^c  

^a Fernandes Távora Hospital   (Brazil)

^b HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^c Hospital Santa Luzia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LIPID; ANTIOXIDANT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; EARLY INTERVENTION; ENERGY EXPENDITURE; ENTERIC FEEDING; FEMALE; FLUID RESUSCITATION; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPOTENSION; INFLAMMATORY DISEASE; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; META ANALYSIS; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SEPSIS; SEPTIC SHOCK; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; METABOLISM; METHODOLOGY; MIDDLE AGED; TIME;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; ENTERAL NUTRITION; FEMALE; GAMMA-LINOLENIC ACID; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958066269     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10267     Document Type: Article

References (48)

1. Martindale RG, McClave SA, Vanek VW, McCarthy M, Roberts P, Taylor B, Ochoa JB, Napolitano L, Cresci G, . American College of Critical Care Medicine; A.S.P.E.N. Board of Directors Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med 2009, 37:1757-1761. 10.1097/CCM.0b013e3181a40116, 19373044, American College of Critical Care Medicine; A.S.P.E.N. Board of Directors.
2. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999, 229:467-477. 10.1097/00000658-199904000-00004, 1191731, 10203078.
3. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 2008, 34:1980-1990. 10.1007/s00134-008-1213-6, 18626628.
4. Pontes-Arruda A. The use of special lipids in the treatment of inflammatory lung disease. Clin Nutr Insight 2007, 33:1-4.
5. Pinsky MR. Antioxidant therapy for severe sepsis: promise and perspective. Crit Care Med 2003, 31:2397-2698. 10.1097/01.CCM.0000084847.90332.96, 14501973.
6. Bulger EM, Maier RV. Lipid mediators in the pathophysiology of critical illness. Crit Care Med 2000, 28(4 Suppl):N27-N36.
7. Mayer K, Schaefer MB, Seeger W. Fish oil in the critically ill: from experimental to clinical data. Curr Opin Clin Nutr Metab Care 2006, 9:140-148. 10.1097/01.mco.0000214573.75062.0a, 16477179.
8. Wanten GJA, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007, 85:1171-1184.
9. Deckelbaum RJ, Worgall TS, Seo T. n-3 fatty acids and gene expression. Am J Clin Nutr 2006, 83(6 Suppl):1520S-1525S.
10. Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J. Anti-inflammatory properties of Ω-3 fatty acids and critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 2008, 34:1580-1592. 10.1007/s00134-008-1142-4, 18461305.
11. Willoughby DA, Moore AR, Colville-Nash PR, Gilroy D. Resolution of inflammation. Int J Immunopharmacol 2000, 22:1131-1135. 10.1016/S0192-0561(00)00064-3, 11137620.
12. Haslett C. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci (Lond) 1992, 83:639-648.
13. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005, 6:1191-1197. 10.1038/ni1276, 16369558.
14. Bannenberg G, Arita M, Serhan CN. Endogenous receptor agonists: resolving inflammation. ScientificWorldJournal 2007, 7:1440-1462.
15. Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 2007, 179:7021-7029.
16. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, Van Hoozen C, Wennberg AK, Nelson JL, Noursalehi M. Effect of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med 1999, 27:1409-1420. 10.1097/00003246-199908000-00001, 10470743.
17. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and γ-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006, 34:1033-1038. A published erratum appears in Crit Care Med 2006, 34:1861, 10.1097/01.CCM.0000206111.23629.0A, 16484911.
18. Pontes-Arruda A, Aragão AM, Albuquerque JD. The effects of enteral feeding with eicosapentaenoic acid, γ-linolenic acid and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006, 34:2325-2333. 10.1097/01.CCM.0000234033.65657.B6, 16850002.
19. Pontes-Arruda A, DeMichele SJ, Seth A, Singer P. The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr 2008, 32:596-605. 10.1177/0148607108324203, 18974237.
20. Clinical Practice Guidelines: Critical Care Nutrition. , http://www.criticalcarenutrition.com/index.php?option=com_content&view=article&id=18&Itemid=10
21. Trials of War Criminal before the Nuremberg Military Tribunals. Control Council Law 1949, 10(2):181-182.
22. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM, . Surviving Sepsis Campaign Management Guidelines Committee Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873. Published errata appear in Crit Care Med 2004, 32:1448, and Crit Care Med 2004, 32:2169-2170, 10.1097/01.CCM.0000117317.18092.E4, 15090974, Surviving Sepsis Campaign Management Guidelines Committee.
23. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, . Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. 10.1056/NEJMoa010307, 11794169, Early Goal-Directed Therapy Collaborative Group.
24. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
25. Bernard GR, Margolis BD, Shanies HM, Ely EW, Wheeler AP, Levy H, Wong K, Wright TJ, . Extended Evaluation of Recombinant Human Activated Protein C United States Investigators Extended evaluation of recombinant human activated protein C United States trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis. Chest 2004, 125:2206-2216. 10.1378/chest.125.6.2206, 15189943, Extended Evaluation of Recombinant Human Activated Protein C United States Investigators.
26. Walker GA. Common Statistical Methods for Clinical Research with SAS Examples 2002, Cary, NC: SAS Institute Inc, 2.
27. Shapiro SS, Wilk MB. An analysis of variance test for normality. Biometrika 1965, 52:591-599.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
29. Peto R, Pike M, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977, 35:1-39. 10.1038/bjc.1977.1, 2025310, 831755.
30. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini J, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson T, Townsend S, Vender JS, Zimmerman JL, Vincent JL, , , , , , , , . International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, European Society of Intensive Care Medicine, European Respiratory Society, International Sepsis Forum, Japanese Association for Acute Medicine, Japanese Society of Intensive Care Medicine, Society of Critical Care Medicine, Society of Hospital Medicine, Surgical Infection Society, World Federation of Societies of Intensive and Critical Care Medicine Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437, International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, European Society of Intensive Care Medicine, European Respiratory Society, International Sepsis Forum, Japanese Association for Acute Medicine, Japanese Society of Intensive Care Medicine, Society of Critical Care Medicine, Society of Hospital Medicine, Surgical Infection Society, World Federation of Societies of Intensive and Critical Care Medicine.
31. Shapiro NI, Howell MD, Talmor D, Lahey DB, Ngo L, Buras J, Wolfe R, Weiss JW, Lisbon A. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006, 34:1025-1032. 10.1097/01.CCM.0000206104.18647.A8, 16484890.
32. Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, Edwards J, Cho TW, Wittlake WA. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 2007, 35:1105-1112. 10.1097/01.CCM.0000259463.33848.3D, 17334251.
33. de Alaniz MJ, Marra CA. Glucocorticoid and mineralocorticoid hormones depress liver Δ 5 desaturase activity through different mechanisms. Lipids 1992, 27:599-604. 10.1007/BF02536117, 1406070.
34. Mills DE, Huang YS, Narce M, Poisson JP. Psychosocial stress, catecholamines, and essential fatty acid metabolism in rats. Proc Soc Exp Biol Med 1994, 205:56-61.
35. Palombo JD, DeMichele SJ, Boyce PJ, Noursalehi M, Forse RA, Bistrian BR. Metabolism of dietary α-linolenic acid vs. eicosapentaenoic acid in rat immune cell phospholipids during endotoxemia. Lipids 1998, 33:1099-1105. 10.1007/s11745-998-0311-x, 9870905.
36. Fan YY, Chapkin RS. Importance of dietary γ-linolenic acid in human health and nutrition. J Nutr 1998, 128:1411-1414.
37. Karlstad MD, DeMichele SJ, Leathem WD, Peterson MB. Effect of intravenous lipid emulsions enriched with γ-linolenic acid on plasma n-6 fatty acids and prostaglandin biosynthesis after burn and endotoxin injury in rats. Crit Care Med 1993, 21:1740-1749. 10.1097/00003246-199311000-00025, 8222692.
38. Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton HF. Dietary supplementation with γ-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr 1997, 127:1435-1444.
39. Brun-Buisson C, Roudot-Thoraval F, Girou E, Grenier-Sennelier C, Durand-Zaleski I. The cost of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis. Intensive Care Med 2003, 29:1464-1471. 10.1007/s00134-003-1877-x, 12856120.
40. Sogayar AM, Machado FR, Rea-Neto A, Dornas A, Grion CM, Lobo SM, Tura BR, Silva CL, Cal RG, Beer I, Michels V, Safi J, Kayath M, Silva E, . Costs Study Group-Latin American Sepsis Institute A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units. Pharmacoeconomics 2008, 26:425-434. 10.2165/00019053-200826050-00006, 18429658, Costs Study Group-Latin American Sepsis Institute.
41. EDEN-Omega NHLBI ARDS Network Prospective, Randomized, Multi-Center Trial of Initial Trophic Enteral Feeding Followed by Advancement to Full-Calorie Enteral Feeding vs. Early Advancement to Full-Calorie Enteral Feeding in Patients With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS) and Prospective, Randomized, Blinded, Placebo-Controlled, Multi-Center Trial of Ω-3 Fatty Acid, γ-Linolenic Acid, and Anti-Oxidant Supplementation in the Management of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS). EDEN-Omega NHLBI ARDS Network., http://clinicaltrials.gov/ct2/show/NCT00609180
42. Palombo JD, DeMichele SJ, Lydon E, Bistrian BR. Cyclic vs continuous enteral feeding with Ω-3 and γ-linolenic fatty acids: effects on modulation of phospholipid fatty acids in rat lung and liver immune cells. JPEN J Parenter Enteral Nutr 1997, 21:123-132. 10.1177/0148607197021003123, 9168366.
43. Mayer K, Gokorsch S, Fegbeutel C, Hattar K, Rosseau S, Walmrath D, Seeger W, Grimminger F. Parenteral nutrition with fish oil modulates cytokines response in patients with sepsis. Am J Respir Crit Care Med 2003, 167:1321-1328. 10.1164/rccm.200207-674OC, 12615625.
44. Heller AR, Rossler S, Litz RJ, Stehr SN, Heller SC, Koch R, Koch T. Ω-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006, 34:972-979. 10.1097/01.CCM.0000206309.83570.45, 16484909.
45. Barbosa VM, Miles EA, Calhau C, Lafuente E, Calder PC. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010, 14:R5. 10.1186/cc8844, 2875515, 20085628.
46. Silva E, de Almeida Pedro M, Beltrami Sogayar AC, Mohovic T, de Oliveira Silva CL, Janiszewski M, Rodrigues Cal RG, Fernandes de Sousa T, Abe TP, de Andrade J, Dias de Matos J, Rezende E, Assunção M, Avezum T, Rocha PCS, Faissol Janot de Matos G, Moreira Bento A, Danielli Corrêa A, Bastos Vieira PC, Knobel E, . Brazilian Sepsis Epidemiological Study Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 2004, 8:R251-R260. 10.1186/cc2892, 522852, 15312226, Brazilian Sepsis Epidemiological Study.
47. Pontes-Arruda A, Martins L, Lima S, Isola AM, Toledo D, Rezende E, Maia M, Magnan G, . the INTERSEPT Study Group Glycemic effects of a high-lipid enteral feeding with EPA, GLA (EPA/GLA) compared to a standard ICU diet in patients with sepsis without organ failures: a prospective, randomized, double-blinded and multicenter trial (INTERSEPT Study). Clin Nutr Suppl 2010, 5:PP013. the INTERSEPT Study Group.
48. Pontes-Arruda A, Martins L, Lima S, Isola AM, Toledo D, Rezende E, Maia M, Magnan G, . the INTERSEPT Study Group Enteral feeding with EPA, GLA (EPA/GLA) in patients with early sepsis without organ dysfunctions: a prospective, randomized, double-blinded multicenter trial (INTERSEPT Study). Clin Nutr Suppl 2010, 5:PP012. the INTERSEPT Study Group.